Traws Pharma earnings were -$34.6M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest TRAW earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$625.0k, down 104.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TRAW reported annual earnings of -$54.7M, with 188.5% growth.
Traws Pharma (NASDAQ: TRAW) reported Q2 2025 earnings per share (EPS) of -$0.11, up 99.46% year over year. Total TRAW earnings for the quarter were -$625.00 thousand. In the same quarter last year, Traws Pharma's earnings per share (EPS) was -$20.52.
As of the last Traws Pharma earnings report, Traws Pharma is currently profitable. Traws Pharma's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $87.91 million, a 353.49% decrease year over year.
What was TRAW's earnings growth in the past year?
As of Traws Pharma's earnings date in Q3 2025, Traws Pharma's earnings has grown year over year. TRAW earnings in the past year totalled -$34.61 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.